Frontiers in Oncology | Hematologic Malignancies

Brief Research Report

Published on 24 Jun 2024

Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience

in Hematologic Malignancies

Elisa Diral
Giulia Furnari
Alessandro Bruno
Raffaella Greco
Daniela Clerici
Sarah Marktel
Francesca Farina
Sara Mastaglio
Luca Vago
Simona Piemontese

Frontiers in Oncology

doi 10.3389/fonc.2024.1391743

1,795 views
3 citations

Original Research

Published on 24 Jun 2024

Development and validation of a nomogram to predict poor efficacy of imatinib in the treatment of newly diagnosed chronic phase chronic myeloid leukemia patients

in Hematologic Malignancies

Yuxin Li
Yilin Zhang
Jin Wang
Aili He
Wanggang Zhang
Xingmei Cao
Yinxia Chen
Jie Liu
Pengyu Zhang
Jianli Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1418417

850 views

Original Research

Published on 21 Jun 2024

Efficacy and safety analysis of combination therapy based on mitoxantrone hydrochloride liposome injection (Lipo-MIT) in relapsed/refractory NK/T-cell lymphoma

in Hematologic Malignancies

Xing-long Wang
He-nan Wang
Lei Yang
Jing Yang
Jia Cong
Zhi-hui Song
Liang Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1396819

1,334 views
1 citation

Editorial

Published on 21 Jun 2024

Editorial: The emerging role of liquid biopsies in hematologic disorders

in Hematologic Malignancies

Ioannis Ntanasis-Stathopoulos
Daniela Drandi

Frontiers in Oncology

doi 10.3389/fonc.2024.1437621

769 views

Review

Published on 20 Jun 2024

Myelofibrosis and allogeneic transplantation: critical points and challenges

in Hematologic Malignancies

Paola Ranalli
Annalisa Natale
Francesco Guardalupi
Stella Santarone
Chiara Cantò
Gaetano La Barba
Mauro Di Ianni

Frontiers in Oncology

doi 10.3389/fonc.2024.1396435

3,018 views

Case Report

Published on 20 Jun 2024

Case report: Splenic inflammatory pseudotumor-like follicular dendritic cell sarcoma (IPT-like FDCS): a trial of immunotherapy and review of the literature

in Hematologic Malignancies

K. A. Resnick
C. Monroe
I. Siddiqi
E. Tam

Frontiers in Oncology

doi 10.3389/fonc.2024.1360726

1,029 views
2 citations

Original Research

Published on 19 Jun 2024

Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy

in Hematologic Malignancies

José Luis Piñana
Lourdes Vazquez
Inmaculada Heras
Tommaso Francesco Aiello
Lucia López-Corral
Ignacio Arroyo
Eva Soler-Espejo
Irene García-Cadenas
Valentín Garcia-Gutierrez
Cristina Aroca

Frontiers in Oncology

doi 10.3389/fonc.2024.1389345

2,125 views
2 citations

Original Research

Published on 13 Jun 2024

No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine—a prospective multicenter study by the Polish Adult Leukemia Group

in Hematologic Malignancies

Krzysztof Mądry
Karol Lis
Elzbieta Sienkiewicz
Joanna Drozd-Sokołowska
Przemysław Biecek
Oktawia Sośnia
Aleksandra Gołos
Magdalena Olszewska-Szopa
Agata Obara
Zuzanna Walkowiak

Frontiers in Oncology

doi 10.3389/fonc.2024.1404322

1,867 views

Case Report

Published on 13 Jun 2024

Case report: Clinical features of pediatric acute myeloid leukemia presenting with cardiac tamponade: a case series study and literature review

in Hematologic Malignancies

Tonghui Li
Xue Tang
Xuezhi He
Lei Zhang
Ya Zhang
Lulu Wang
Shilin Liu
Guichi Zhou
Feiqiu Wen
Sixi Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1391768

1,275 views

Original Research

Published on 13 Jun 2024

Complete elimination of hyperleukocytosis risk in AML through early high-quality disease remission

in Hematologic Malignancies

Guoqing Lyu
Wenting Lyu

Frontiers in Oncology

doi 10.3389/fonc.2024.1412583

1,440 views
1 citation

Original Research

Published on 11 Jun 2024

Risk score constructed with neutrophil extracellular traps-related genes predicts prognosis and immune microenvironment in multiple myeloma

in Hematologic Malignancies

Gongzhizi Gao
Rui Liu
Dong Wu
Dandan Gao
Yang Lv
Xuezhu Xu
Bingjie Fu
Zujie Lin
Ting Wang
Aili He

Frontiers in Oncology

doi 10.3389/fonc.2024.1365460

2,135 views

Review

Published on 11 Jun 2024

Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

in Hematologic Malignancies

Ana Costa Cordeiro
George Durisek
Marjorie Vieira Batista
Jayr Schmidt
Marcos de Lima
Evandro Bezerra

Frontiers in Oncology

doi 10.3389/fonc.2024.1404351

3,016 views
1 citation

Original Research

Published on 11 Jun 2024

Liposomes have a direct effect on multiple myeloma: a Mendelian randomization study

in Hematologic Malignancies

Yingbin Zhong
Yanhao Li
Weipeng Sun
Mingfeng Xiao

Frontiers in Oncology

doi 10.3389/fonc.2024.1404744

2,654 views

Original Research

Published on 06 Jun 2024

Performance of MYC, BCL2, and BCL6 break-apart FISH in small biopsies with large B-cell lymphoma: a retrospective Cytopathology Hematopathology Interinstitutional Consortium study

in Hematologic Malignancies

Joshua R. Menke
Umut Aypar
Charles D. Bangs
Stephen L. Cook
Srishti Gupta
Robert P. Hasserjian
Christina S. Kong
Oscar Lin
Steven R. Long
Amy Ly

Frontiers in Oncology

doi 10.3389/fonc.2024.1408238

2,046 views

Review

Published on 05 Jun 2024

The treatment of follicular lymphoma with CD19-directed chimeric antigen receptor T-cell therapy

in Hematologic Malignancies

Ryan Jacobs
Caron Jacobson

Frontiers in Oncology

doi 10.3389/fonc.2024.1384600

2,605 views

Review

Published on 04 Jun 2024

Allogeneic stem cell transplantation in multiple myeloma: is there still a place?

in Hematologic Malignancies

Carmine Liberatore
Francesca Fioritoni
Mauro Di Ianni

Frontiers in Oncology

doi 10.3389/fonc.2024.1402106

2,463 views
1 citation